On heels of Lumakras data drop, new KRAS idea emerges; Bristol Myers, AbbVie, Rubius headline busy week of restructuring; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Longtime Endpoints readers would know that every year, editor-in-chief John Carroll handpicks a group of up-and-coming private biotech upstarts that are promising to shake up the field — or fail loudly. This year’s Endpoints 11 will be announced against a dramatic backdrop, and we’ll be presenting the awards in person. Join us for the celebration — featuring a fireside chat with Nobel Prize laureate Phillip Sharp — in Boston.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 150,300+ biopharma pros reading Endpoints daily — and it's free.